| Title |
Bispecific Antibodies in Multiple Myeloma: Present and Future
|
|---|---|
| Published in |
Blood Cancer Discovery, August 2021
|
| DOI | 10.1158/2643-3230.bcd-21-0028 |
| Pubmed ID | |
| Authors |
Guido Lancman, Dahniel L. Sastow, Hearn J. Cho, Sundar Jagannath, Deepu Madduri, Samir S. Parekh, Shambavi Richard, Joshua Richter, Larysa Sanchez, Ajai Chari |
X Demographics
The data shown below were collected from the profiles of 33 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 13 | 39% |
| United Kingdom | 2 | 6% |
| France | 1 | 3% |
| Malaysia | 1 | 3% |
| Brazil | 1 | 3% |
| Mexico | 1 | 3% |
| Unknown | 14 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 17 | 52% |
| Scientists | 9 | 27% |
| Practitioners (doctors, other healthcare professionals) | 4 | 12% |
| Science communicators (journalists, bloggers, editors) | 3 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 77 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 16% |
| Other | 8 | 10% |
| Student > Bachelor | 4 | 5% |
| Student > Postgraduate | 3 | 4% |
| Student > Master | 3 | 4% |
| Other | 7 | 9% |
| Unknown | 40 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 19% |
| Biochemistry, Genetics and Molecular Biology | 8 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Immunology and Microbiology | 3 | 4% |
| Agricultural and Biological Sciences | 2 | 3% |
| Other | 4 | 5% |
| Unknown | 42 | 55% |
Attention Score in Context
This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2024.
All research outputs
#1,199,745
of 25,391,471 outputs
Outputs from Blood Cancer Discovery
#49
of 208 outputs
Outputs of similar age
#27,993
of 426,726 outputs
Outputs of similar age from Blood Cancer Discovery
#5
of 18 outputs
Altmetric has tracked 25,391,471 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 208 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.4. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,726 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.